Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-04

Clinical Trial Update: The Role of C-11 Choline PET in Patients With Prostate Cancer [NA]

View source ↗

Summary

The study NCT02852122 completed an evaluation of C-11 choline PET imaging in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • C-11 Choline PET tracer (Choline labeled with carbon-11)

Snippet

Sponsor: Chang Gung Memorial Hospital | Conditions: Latent Cancer Prostate | NA | Status: COMPLETED